Skip to main content
Caplight Logo









Droplet Biosciences

Droplet Biosciences

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://dropletbiosci.com/

Last Round

Series A

Dec 13, 2023

Total Funding Raised

$20.96M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Droplet Biosciences is a biotechnology company that provides sensitive cancer diagnostics through a non-invasive lymph liquid biopsy platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

liquid biopsyminimal residual diseaseMRDmolecular diagnosticscirculating tumor DNActDNAcancer recurrenceNGSnext-generation sequencingcancer monitoringbioinformaticsprecision medicineliquid biopsy testcancer screeningliquid biopsy startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Droplet Biosciences Comparables

Compare Droplet Biosciences with similar companies based on industry and business-model similarity.

Droplet Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Adela
79%
Quest Diagnostics
78%
NeoGenomics Inc
76%

Droplet Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 13, 2023
SeedMar 16, 2023
SeedMay 27, 2021

Key People

Founding team and executive leadership

Greg Gosch

President and CEO

Executive Team

Droplet Biosciences Investors

Notable investors and investment history

Droplet Biosciences investors
InvestorRounds
Engine VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 31% MoM, reaching 1.7K.

  • Jul 26, 2026

    Monthly visitors increased 277% MoM.

Droplet Biosciences Filings

Explore SEC and related filing metadata, where available.

Droplet Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Droplet Biosciences's valuation, stock price, and market status.

Is Droplet Biosciences a public or private company?

Droplet Biosciences is a private company.

What is the current stock price of Droplet Biosciences?

Droplet Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Droplet Biosciences worth (valuation)?

Valuation information for Droplet Biosciences is not publicly available.

Can I buy Droplet Biosciences stock?

Droplet Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Droplet Biosciences's last funding round?

Droplet Biosciences's most recent funding round was Series A on December 13, 2023.

Who are the main investors in Droplet Biosciences?

Key investors in Droplet Biosciences include Engine Ventures.

Will Droplet Biosciences IPO soon?

No public IPO plans have been announced for Droplet Biosciences.

How can I track Droplet Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Droplet Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range19
Year Founded2021
Last FundingDec 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?